Workflow
中国平安(601318):25年寿险NBV有韧性,股息政策积极

Investment Rating - The investment rating for the company is "Buy" (首次) [5] Core Views - The company's 2025 life insurance NBV shows resilience, and the dividend policy is positive [5] - In Q1 2025, the company's OPAT and NBV performance was strong, with a 2.4% year-on-year growth in OPAT to 37.9 billion yuan, despite a decline in group revenue and net profit [6] - The life insurance business remains a core pillar, contributing 71.7% of net profit and 70.9% of OPAT in Q1 2025 [7] Summary by Sections Market Performance - The closing price on May 29, 2025, was 53.52 yuan, with a total market capitalization of 974,611.76 million yuan [3] Financial Performance - In Q1 2025, the group revenue and net profit decreased by 5.2% and 26.4% year-on-year, respectively, to 232.8 billion yuan and 27 billion yuan [6] - The life insurance business achieved a 34.9% growth in NBV, contributing to a 5% OPAT growth [6][7] Business Outlook - The life insurance capacity may face pressure in 2025, requiring strategic products to support sales [7] - The company expects to see rapid growth in its bancassurance market share, with a 171% year-on-year increase in NBV in Q1 2025 [7] - The NBV margin improved by 11.4 percentage points year-on-year to 28.3% in Q1 2025, indicating potential for further margin enhancement [7] Dividend Policy - The company maintains a positive dividend policy, with a commitment to increasing the absolute value of cash dividends annually [10] - The current dividend yield for A-shares and H-shares is 4.76% and 6.00%, respectively [10] Earnings Forecast - The forecasted net profit for 2025 is 135.1 billion yuan, with a year-on-year growth of 6.7% [11] - The projected earnings per share for 2025 is 7.42 yuan, with a P/E ratio of 7.2 [11]